Effect of differentiation agents on expression of CA 125, alkaline phosphatase, and cytokeratins in human ovarian adenocarcinoma cells (OVCA 433)

This publication has 23 references indexed in Scilit:

• An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma
  Gynecologic Oncology, 1988
• The Effect of Sodium Butyrate and Retinoic Acid on Growth and CEA Production in a Series of Human Colorectal Tumor Cell Lines Representing Different States of Differentiation
  Cancer Investigation, 1988
• Serum CA 125 levels in epithelial ovarian cancer: relation with findings at second‐look operations and their role in the detection of tumour recurrence
  BJOG: An International Journal of Obstetrics and Gynaecology, 1987
• CA 125 Serum Levels Correlated With Second-Look Operations Among Ovarian Cancer Patients
  Obstetrics & Gynecology, 1986
• Tumour‐associated antigen CA 125 in patients with ovarian cancer
  BJOG: An International Journal of Obstetrics and Gynaecology, 1985
• Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer
  American Journal of Obstetrics and Gynecology, 1985
• Effect of sodium butyrate on human breast carcinoma (MCF-7) cellular proliferation, morphology, and CEA production
  Breast Cancer Research and Treatment, 1984
• Tissue Distribution of a Coelomic- Epithelium-Related Antigen Recognized by the Monoclonal Antibody OC125
  International Journal of Gynecological Pathology, 1983
• Effect of polar organic compounds on leukemic cells: Butyrate-induced partial remission of acute myelogenous leukemia in a child
  Cancer, 1983
• Reactivity of a monoclonal antibody with human ovarian carcinoma.
  Journal of Clinical Investigation, 1981